Enhanced Adenovirus Vaccine Safety Surveillance in Military Setting, United States
John K. Iskander, Scott Blanchet, Caitlin Springer, Patrick Rockwell, Dana Thomas, Satish K. Pillai
Abstract
The US Coast Guard Academy began adenovirus vaccination of incoming cadets in 2022. Of 294 vaccine recipients, 15%-20% had mild respiratory or systemic symptoms within 10 days postvaccination but no serious adverse events after 90 days. Our findings support the continued use of adenovirus vaccines in congregate military settings.
Topics & Concepts
VaccinationMedicineMilitary personnelAdverse effectVirologyCoast guardImmunologyInternal medicinePolitical scienceGeographyEnvironmental protectionLawVirus-based gene therapy researchViral Infections and Outbreaks ResearchViral gastroenteritis research and epidemiology